Novartis AG (NVSEF)
Novartis AG Statistics
Share Statistics
Novartis AG has 1.9B shares outstanding. The number of shares has increased by -3.01% in one year.
| Shares Outstanding | 1.9B |
| Shares Change (YoY) | -3.01% |
| Shares Change (QoQ) | -3.01% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.69B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.23M, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 2.23M |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.11% |
| Short Ratio (days to cover) | 9.28 |
Valuation Ratios
The PE ratio is 16.09 and the forward PE ratio is null. Novartis AG's PEG ratio is -0.74.
| PE Ratio | 16.09 |
| Forward PE | n/a |
| PS Ratio | 3.72 |
| Forward PS | null |
| PB Ratio | 4.36 |
| P/FCF Ratio | 13.92 |
| PEG Ratio | -0.74 |
Enterprise Valuation
Novartis AG has an Enterprise Value (EV) of 211.95B.
| EV / Sales | 4.1 |
| EV / EBITDA | 10.23 |
| EV / EBIT | 12.03 |
| EV / FCF | 15.35 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.04 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 2.26 |
| Interest Coverage | 14.46 |
Financial Efficiency
Return on Equity is 27.11% and Return on Invested Capital is 15.55%.
| Return on Equity | 27.11% |
| Return on Assets | 11.68% |
| Return on Invested Capital | 15.55% |
| Revenue Per Employee | $681.6K |
| Profits Per Employee | $157.36K |
| Employee Count | 75,883 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | 1.7B |
| Effective Tax Rate | 12.47% |
Stock Price Statistics
The stock price has increased by 15.41% in the last 52 weeks. The beta is 0.55, so Novartis AG's price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | 15.41% |
| 50-Day Moving Average | 108.56 |
| 200-Day Moving Average | 107.2 |
| Relative Strength Index (RSI) | 44.94 |
| Average Volume (20 Days) | 92.24K |
Income Statement
In the last 12 months, Novartis AG had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.97.
| Revenue | 51.72B |
| Gross Profit | 38.9B |
| Operating Income | 14.54B |
| Net Income | 11.94B |
| EBITDA | 20.71B |
| EBIT | 14.65B |
| Earnings Per Share (EPS) | 5.97 |
Balance Sheet
The company has 11.46B in cash and 31.26B in debt, giving a net cash position of -19.8B.
| Cash & Cash Equivalents | 11.46B |
| Total Debt | 31.26B |
| Net Cash | -19.8B |
| Retained Earnings | 0 |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 17.62B and capital expenditures -3.81B, giving a free cash flow of 13.8B.
| Operating Cash Flow | 17.62B |
| Capital Expenditures | -3.81B |
| Free Cash Flow | 13.8B |
| FCF Per Share | 6.9 |
Margins
Gross margin is 75.2%, with operating and profit margins of 28.12% and 23.09%.
| Gross Margin | 75.2% |
| Operating Margin | 28.12% |
| Pretax Margin | 26.37% |
| Profit Margin | 23.09% |
| EBITDA Margin | 40.05% |
| EBIT Margin | 28.12% |
| FCF Margin | 26.69% |
Dividends & Yields
NVSEF pays an annual dividend of $3.96, which amounts to a dividend yield of 3.3%.
| Dividend Per Share | $3.96 |
| Dividend Yield | 3.3% |
| Dividend Growth (YoY) | 5.8% |
| Payout Ratio | 67.43% |
| Earnings Yield | 6.21% |
| FCF Yield | 7.18% |
Analyst Forecast
Currently there are no analyst rating for NVSEF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 4, 2023. It was a forward split with a ratio of 211:200.
| Last Split Date | Oct 4, 2023 |
| Split Type | forward |
| Split Ratio | 211:200 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |